Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
IARTIntegra Lifesciences Holdings Corp
| Figure | IARTIntegra Lifesciences Holdings CorpFY2025 · Dec |
|---|---|
| Revenue | $1.64B |
| Revenue, yoy | +1.5% |
| Net income | $516.47M |
| Net income, yoy | −7,337.7% |
| Net margin | -31.6% |
| Free cash flow | $31.05M |
| FCF margin | -1.9% |
| EPS, diluted | $6.74 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed